Monday 3 August 2015
 
»
Tag
 
»
Hikma

Hikma to acquire Roxane for $2.65bn

Hikma Pharmaceuticals, a leading multinational pharmaceutical group, is set to acquire Roxane Laboratories and Boehringer Ingelheim Roxane, from Boehringer Ingelheim. The acquisition has an aggregate value of gross consideration o

More…

Hikma in bid for Boehringer's generics unit

Jordan's Hikma Pharmaceuticals has emerged as a bidder for German drugmaker Boehringer Ingelheim's generics unit Roxane Labs, Bloomberg reported, citing people familiar with the matter. Other bidders for the US-based Boehr

More…

Hikma in bid for Boehringer's generics unit

Jordan's Hikma Pharmaceuticals has emerged as a bidder for German drugmaker Boehringer Ingelheim's generics unit Roxane Labs, Bloomberg reported, citing people familiar with the matter. Other bidders for the US-based Boehr

More…

Hikma Pharmaceuticals posts 9pc revenue increase

Hikma Pharmaceuticals, a leading multinational pharmaceutical group with operations across the Middle East and North Africa (Mena), Europe and the United States, has posted a nine per cent increase in revenue, with returns of $1.4 billion last y

More…

Hikma signs license deal with Azanta for Nimoral

Hikma Pharmaceuticals, a leading multinational pharmaceutical group, has signed an exclusive license agreement with specialty pharmaceutical company Azanta for its proprietary cancer product Nimoral (nimorazole).   Nimoral is

More…

Hikma delivers insights on Mena growth markets

Hikma Pharmaceuticals, a fast growing multinational pharmaceutical group, provided insights on the impact of recent societal, political and economic developments on growth markets in the Arab world at the recently concluded World Economic Forum

More…

Hikma acquires assets of US pharma group

Hikma Pharmaceuticals, a leading medical group in the region, has signed an agreement with Boehringer Ingelheim Group of Companies to acquire the assets of Bedford Laboratories for $300 million. Hikma is a fast growing multination

More…

Hikma, Midroc JV targets Ethiopia

Jordan's Hikma Pharmaceuticals has formed a joint venture with Sheikh Mohammed Hussein Al Amoudi's Midroc Group to enter the Ethiopian healthcare market, where health spending is likely to more than doubl

More…

Jordan pharma group mulls injectables unit sale

Jordan-based Hikma Pharmaceuticals said it is reviewing options for its lucrative injectables business after receiving several unsolicited expressions of interest, driving up its shares nearly 8 per cent to a life-high. The inject

More…

Hikma’s H1 revenue hits $523m, up 35pc

UK-based Hikma Pharmaceuticals, a fast growing global pharmaceutical group, has posted revenue of $532.3 million for the first half of the year, marking a 34.8 per cent increase over the same period last year. The group, with sales in m

More…
 1 2 3 4 5 >  Last ›

calendarCalendar of Events

Ads